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The functions of eosinophils not  shared  by neutrophils remain  obscure  in 
spite of numerous investigations and an enormous amount of literature dealing 
with observations of laboratory animals and patients (1-3). It seems likely that 
the specific functions of the eosinophil are related to  the distinctive granules 
associated with this cell.  In the past,  a  variety of investigators have purified 
eosinophil  granules  and  investigated  their  properties.  Vercauteren  isolated 
eosinophil granules from horse eosinophils and  analyzed the granule material 
(4,  5).  His  studies  suggested  the  presence  of  arginine-rich  proteins  in  the 
granules which functioned as an antihistamine. Archer and Hirsch purified rat 
and  horse  eosinophils  and  isolated  granules  from  these  cells.  Their  studies 
showed  that  eosinophil  granules  differed  from  neutrophil  granules  in  that 
eosinophil granules contained a high content of peroxidase and did not contain 
lysozyme and phagocytin (6).  More recently Gessner and his  associates ana- 
lyzed the proteins in guinea pig eosinophil granules and identified four major 
and several minor proteins  (7). 
We have described methods for the purification of eosinophils and neutro- 
phils from the peritoneal cavity of the guinea pig (8) and have identified a major 
basic protein (MBP) 1 present in eosinophil granules (9). This protein does not 
possess peroxidase activity and accounts for approximately 55 %  of the total 
granule protein. In this report we have extended our earlier observations on the 
eosinophil MBP and have shown that it has a mol wt of about 11,000, that it is 
characterized by a high content of arginine, that it possesses two free sulfhydryl 
groups per molecule, and  that  it readily polymerizes and  becomes insoluble. 
The MBP does not  increase vascular permeability nor does it  contract ileal 
muscle. It has only weak, if any, antihistaminic activity and is considerably less 
* Supported in part by grants from  the National Institutes of Health, AI-9728, AI-11483, 
and HL-15381 and from the Mayo Foundation. 
1  Abbreviations used in this paper: ATEE, acetyltyrosine-ethyl ester; BAEE, benzoyl-L- 
arginine ethyl ester; DTNB, 5,5'-dithiobis (2-nitrobenzoic  acid); DTT, dithiothreitol; MBP, 
major basic protein; TAME, tosyl-arginine  methyl ester. 
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potent  than  histones  as bactericidal  agents.  The MBP  precipitates  with DNA 
and neutralizes heparin.  Finally, it readily activates mercuripapain  and is more 
active in this respect than cysteine. 
Materials and Methods 
Materials.--Sucrose,  EDTA, and hydrogen peroxide were obtained from Fisher Scientific 
Co.,  Pittsburgh,  Pa.  Dithiothreitol  (DTT),  diisopropylfluorophosphate,  benzoyl-L-arginine 
ethyl ester (BAEE), iodoacetamide, diphenylamine, histone (type IV, arginine rich), histamine, 
bradykinin, Compound 48/80, tosyl-arginine methyl ester (TAME), acetyltyrosine-ethyl ester 
(ATEE), 5,5'-dithiobis  (2-nitrobenzoic acid)  (DTNB), and protamine were purchased  from 
Sigma Chemical Co., St. Louis, Mo. Paratoluene sulfonic acid and formic acid were obtained 
from J. T. Baker Chemical Co., Phillipsburg, N. J. DNA and papain were purchased from 
Worthington Biochemical Corporation, Freehold, N. J. Heparin and D-ribose were obtained 
from Calbiochem, La Jolla,  Calif. Orcinol was purchased  from K  & K  Laboratories,  Inc., 
Plainview, N.  Y., and  Bayol from the Exxon Corporation, New York.  Bovine trypsin was 
purchased from Boehringer & Soehne,  Mannheim,  Germany. Bio-Gel Agarose A-0.5 M  was 
purchased from Bio-Rad Laboratories, Richmond, Calif. 
Preparation of Eosinophil Granules.--Eosinophil  leukocytes were isolated from peritoneal 
fluids  obtained  from  the guinea pig and  granules  were liberated  from purified  eosinophils 
essentially as described previously (9).  Briefly, suspensions  of cells in 0.34  M  sucrose  were 
repeatedly pipetted with a  Pasteur pipette. After centrifugation at 400  g for 10 rain at 4°C 
to remove unbroken cells the opalescent supernate was transferred  to another tube and cen- 
trifuged at 5,000 g for 20 rain at 4°C. The granules were solubilized  in 0.025 M pH 4.3 acetate 
buffer or in 0.01  M  HC1 and  analyzed  by electrophoresis on polyacrylamide gels  or by gel 
filtration on columns of Sephadex G-50 (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) 
1.2  X  45 cm. As shown previously (9)  two principal fractions emerge from the column, one 
at  the void volume containing many proteins, including peroxidase, and  another,  at about 
twice the void volume, containing the MBP. In these experiments we noted that the use of 
freshly prepared 0.34 M sucrose  was important to obtain high yields of granule proteins. 
Electrophoresis on Polyacrylamide Ge/s.--Solubilized eosinophil granules were analyzed by 
electrophoresis in  15%  polyacrylamide gels at pH 3  in  the presence  of 6.25  M  urea  (10). 
Eosinophil granule proteins were also analyzed by electrophoresis in 8% polyacrylamide gels 
containing 1% SDS using the procedure described by Fairbanks et al. (11). Gels were stained 
as described by Fairbanks et al. (11). 
Physiochemical Analyses  of MBP and Solubilized Eosinophil Granules.--The  MBP eluting 
in the second peak was analyzed for its protein content by the biuret procedure (12) and  for 
its content of carbohydrate by the phenol-sulfuric acid procedure (13). Solubilized eosinophil 
granules were analyzed for their content of ribose by the orcinol reaction (12) and for deoxy- 
ribose by the diphenylamine procedure  (12). The number  of free sulfhydryl groups in the 
MBP  was  determined  by  reaction  with  DTNB  (Ellman's  reagent)  (14, 15). Amino  acid 
analysis was performed as described by Spackman et al.  (16) using a  Beckman model 119 
automatic amino acid analyzer  (Beckman  Instruments,  Inc., Fullerton, Calif.).  Samples  of 
MBP were hydrolyzed for 24, 48, and  72 h in 6 M  HCI at ll0°C. For the determination of 
cysteine content, the protein was oxidized with performic acid as described by Moore (17) and 
Hits (18) and then hydrolyzed as described above. For determinations of tryptophan content, 
MBP was hydrolyzed using p-toluene sulfonic acid as described by Liu (19, 20). The extinction 
coefficient,  Elf°m, of MBP was determined by the method of Babul and Stellwagen using  the 
model E analytical ultracentrifuge (21). 
The apparent molecular weight of MBP was determined by gel filtration of the reduced 
carboxymethylated protein on a calibrated  10% agarose column (Bio-Gel A-0.5 M, Bio-Rad 
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with a  series of polypeptides of known amino acid sequence in terms of N,  the number of 
amino acid residues in the protein. The value of N  determined experimentally by the elution 
position of the sample, when combined with ~ro,  the mean residue weight determined from 
composition studies, provides a measure of M, the molecular weight  of the protein: M  = N~lo. 
The determination of M by this technique is accurate to about -4- 5% and depends upon the 
assumption that the protein behaves as a  linear random coil in 6 M  guanidinium chloride, 
an assumption valid for most polypeptides and proteins in this solvent. 
Biological Analyses of MBP.--Antibacterial activity of the MBP was tested using a modi- 
fication of the procedures described by Muschel and Treffers (24) and by Zeya and Spitznagel 
(25).  Single  colonies were  removed from blood agar  plates and  after overnight growth in 
trypticase soy broth the bacteria were sedimented at 1,200 g for 20 min. After resuspension 
in 5 ml of broth a sample of 0.25-0.5 ml was incubated in 10-ml broth until  the bacteria were 
in the log phase of growth. At this point they were diluted to an absorbance of 0.15  at 650 
nm and suspended in 0.05 M pH 7 citrate-phosphate buffer.  In these experiments eosinophil 
granules were  solubilized  in  0.01  M  HCI  and  fractionated on  columns of Sephadex G-50 
equilibrated with 0.02 M pH 4.3 citrate buffer.  Before testing, fractions containing the MBP 
were adjusted to pH 7 with 1 M  NaOH and 0.05  M  citrate-phosphate buffer.  Varying con- 
centrations of MBP or histone were incubated with test bacteria in citrate-phosphate buffer 
for 1 h, and 5 ml of trypticase soy broth was added. Incubation was continued until control 
tubes had an absorbance at 650 nm between 0.3 and 0.6. The test cultures were analyzed at the 
completion of the experiment to ensure that the same populations of bacteria were present 
as at the beginning and that overgrowth by a contaminant had not occurred. The concentra- 
tion of protein needed for 50% killing was taken as the end point. 
The ability of the MBP to alter vascular permeability was tested in 400 g guinea pigs as 
described by Miles and Miles (26).  Guinea pigs were injected intravenously with 0.5  ml of 
1% Evans blue in saline after the skin of the back had been shaved. Various materials were 
injected and the size and intensity  of blueing were measured 15 rain after intracutaneous injec- 
tion of the test materials, using the grading scheme suggested by Levine (27). 
The contractibility of the isolated guinea pig ileum in the presence of histamine, brady- 
kinin,  and MBP was tested using the methods described by Code and  McIntire  (28) and 
Austen (29). A 5-ml bath and recording device obtained from Adaps, Inc., Dedham, Mass., 
were used in these experiments. Fractions containing MBP were adjusted to pH 8 with 1 M 
Tris-HC1 and no more than 0.2 ml was added to the gut bath. 
The effect of the MBP on synthetic substrates and on the activity of enzymes was meas- 
ured with a  Radiometer pH-stat equipped with an autoburette and an automatic recorder 
(Radiometer Co., Copenhagen, Denmark). For determination of the activity of the MBP on 
synthetic substrates the assay mixture contained 165 #g of MBP in 0.5 ml of 0.03 M pH 7.4 
phosphate buffer; 0.5 ml of 0.03 M TAME or ATEE; and 0.5 ml of 0.03 M pH 7.4 phosphate 
buffer.  The reaction was carried out at 37°C in a  thermostatically controlled vessel and the 
reaction velocity was measured by the addition of 10 mM NaOH. The assay for measuring 
trypsin inhibitory activity was the same except that 4 or 10 #g of trypsin in 0.1 ml of phos- 
phate buffer was added. With this procedure less than 1/zg of trypsin inhibition can be de- 
tected. 
The ability of MBP to neutralize heparin was tested and compared to protamine using a 
modification of the procedure described by Bowie et al.  (30). Heparin and basic protein were 
mixed and then whole guinea pig blood obtained by cardiac puncture was added to a 10 X  75 
mm glass tube. The time required for clotting to occur was recorded. 
RESULTS 
Preparation of Eosinophil Granules.--In  all of our earlier experiments we had 
prepared granules from eosinophils purified from peritoneal washings by sedi- 
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yield of granule protein because of the loss  of eosinophils during purification 
(8). We determined whether eosinophil granules could be prepared  from the 
peritoneal cell populations containing eosinophils, about 40-50%,  and mono- 
nuclear  cells,  lymphocytes,  and  macrophages,  without  prior  purification of 
eosinophils. We found that the homogeneity of granule preparations as judged 
by electron microscopy was essentially the same as when the granules were pre- 
pared  from  purified  eosinophils.  In  fact,  granules  isolated  from  mixed  cell 
preparations appeared to retain their structural integrity better than those pre- 
pared  from  purified  eosinophils.  Also,  analyses  by  electrophoresis  in  poly- 
acrylamide gels  of solubilized granules prepared  from purified eosinophils or 
from mixed peritoneal cells did not reveal a difference in the patterns and both 
contained the MBP.  Finally, injection of  15  ml of Bayol into the peritoneal 
cavity of the guinea pig yielded an exudate containing almost entirely mono- 
nuclear cells and virtually devoid of eosinophils (< 0.1%). When these mono- 
nuclear cell preparations were carried through the procedures for preparation 
and analysis of granules, no MBP component was seen. These results indicated 
that eosinophil granules could be separated from the cytoplasmic constituents of 
eosinophils and  other  contaminating cells.  In  all of the  experiments in  this 
report, except as noted, we prepared eosinophil granules from peritoneal wash- 
ings without prior purification of eosinophils. By eliminating this purification 
step our yield of granule protein was increased about fourfold. 
The presence of a basic protein derived from eosinophil granules raised the 
question whether this might be a  histone. Although we had not noted nuclei 
when granule preparations were examined by  electron microscopy,  we  mea- 
sured the content of deoxyribose in  solubilized whole granules from  purified 
eosinophils. No deoxyribose was detected. Analyses of  the  granule  solutions 
for ribose revealed a content of 5.2 %. This degree of contamination with ribose 
is likely explained by the presence of ribosomes in the 5,000 g sediment (9). 
Purification of the MBP.--Previously we had  shown that  fractionation of 
solubilized eosinophil granules on Sephadex G-50 yielded three peaks, the bulk 
of the 280 nm absorbance being associated with the second peak. As shown in 
Fig. 1, analyses of these fractions by electrophoresis on urea-acetic acid poly- 
acrylamide gels sometimes showed a single component, but in other experiments 
a series of bands were seen or alternatively a smear above the MBP was  noted. 
Also when MBP  containing fractions were concentrated or frozen at  --70°C, 
usually several bands were noted. We performed a variety of studies to deter- 
mine whether these findings represented another component in the second peak 
fractions or whether they were a consequence of polymerization or proteolysis. 
First, a  variety of different conditions for disruption of granules were tested 
including freezing and thawing in distilled water or in the presence of 0.15  M 
NaC1 or in 0.05  M  pH 6.5 phosphate buffer. Also granules were disrupted by 
exposure to distilled water, or 0.01 M HC1, or by exposure to various detergents, 
including Tween 80  (Atlas Chemical Industries Inc., Wilmington, Del.),  Brij GLEICH, LOEGERING, KUEPPERS~ BAJAJ,  AND MANN  317 
FIo. 1.  Analysis of MBP on urea-acetic acid polyacrylamide gels. MBP containing  frac- 
tions from the second peak of a Sephadex G-50 column were pooled, concentrated,  and  the 
concentrate frozen at --70°C for 24 h. The MBP peak and the concentrate of the peak  were 
analyzed by electrophoresis on the same day and the frozen concentrate  was analyzed  a  day 
later.  The patterns  produced by the pool are on the left, by the concentrate  in  the  middle, 
and by the frozen concentrate  on the right. The pH 4.3 acetate buffer used in this  particular 
Sephadex G-50 separation  contained  0.1~  hexadecyltrimethylammonium  bromide and  the 
faint band below the MBP especially evident in the concentrates represents the presence  of 
the detergent. 
35  (Atlas  Chemical  Industries  Inc.),  or Triton X  (Rohm and Haas Co., Phila- 
delphia,  Pa.),  all  at  1%.  However,  the  same variability  in  the  appearance  of 
the MBP on the polyacrylamide gels was seen in all these experiments.  Second, 
banding patterns  were not altered by using purified  eosinophils as opposed to 
whole peritoneal cells as starting material. Third, inclusion  of 0.1% hexadecyl- 
trimethylammonium bromide (7)  in the 0.05 M  pH 4.3 acetate buffer used for 
disruption  and  fractionation  of granules  did  not  alter  the  appearance  of the 
MBP. Finally, disruption  of granules in the presence of diisopropylfluorophos- 
phate and EDTA did not change the banding pattern. 318  PROPERTIES  OF  MAJOR  BASIC  PROTEIN 
In none of the above experiments did we observe bands migrating faster than 
the MBP, and we suspected that the presence of multiple bands might be due to 
polymerization  of  the  MBP.  To  investigate  this  possibility,  we  performed 
electrophoresis in 8 % polyacrylamide gels containing 1% SDS with and without 
reduction with DTT. The results of a typical experiment are shown in Fig. 2. 
Fractions containing MBP were concentrated and stored at  -70°C. Analysis 
without reduction revealed that the bulk of the protein did not enter the gel and 
a "cap" was prominent. Reduction with DTT abolished the cap and the protein 
had the expected position in the gel. The same result was seen when MBP was 
frozen in the pH 4.3 acetate buffer, indicating that the lower pH did not appre- 
ciably interfere with the polymerization process. In other experiments, we ob- 
served the presence of multiple bands above the MBP band, as shown in Fig. 3. 
Analysis revealed that these additional bands had molecular weights consistent 
with the formation of a series of polymers from a monomer with a mol wt of ap- 
proximately 11,000.  Furthermore, we found that a single band was produced by 
the MBP regardless of manipulations, providing it was reduced at pH 8 with 
DTT and alkylated with iodoacetamide before electrophoresis on the SDS poly- 
acrylamide  gels.  These  experiments indicated  that  a  single  component  was 
present  and  that polymer formation was a  consequence  of the formation of 
disulfide bonds. 
Physiochemical  Properties  of the MBP.--The  above experiments  indicated 
that the  MBP had a tool wt of approximately 11,000  and likely contained at 
least  two  free  sulfhydryl  groups.  The  molecular  weight  of  the  reduced  and 
carboxymethylated protein was measured by gel filtration chromatography on 
columns of 10 % agarose equilibrated with 6 M guanidinium chloride. As shown 
in Fig. 4  a  single peak was identified with  a tool wt of 11,000.  The peak was 
symmetrical and there was no evidence of any other peaks, indicating that the 
MBP was composed of a  single polypeptide chain. 
The  amino  acid  content  of the  MBP  is  shown  in Table I. The protein  is 
remarkable in that it contains 13 % arginine. The presence of tryptophan indi- 
cates that the MBP is not a histone (31). In Table II, the molecular weights of 
the  MBP  determined  by  three  independent  methods  are  listed.  The  MBP 
was  also  analyzed  for  carbohydrate  and  less  than  1%  carbohydrate  was 
present.  The  extinction  coefficient obtained in  the  analytical  ultracentrifuge 
1%  was E1 em  ~  25.9,  a  value  in remarkably good agreement with the result from 
biuret analysis E 1~°  I  em  =  26.3  using human serum  albumin  as  a  standard.  An- 
alyses to determine the content  of available  sulfhydryl  groups  are  shown  in 
Table III  and  indicate  that  two  available  sulfhydryl  groups  are  present. 
Because  a  total  of  six  half-cystine  residues  are  present,  it  is  clear  that 
four of these  are joined  to  form  two disulfide bonds and that the remaining 
two are present in the reduced form. 
Biological Properties of the MBP.--A variety of experiments were performed 
to define biological activities associated with the MBP. Initially we tested the GLEICH,  LOEGERING~ KUEPPERS~ BAJAJ~ AND  MANN  319 
FIG. 2.  Analysis of MBP on SDS polyacrylamide gels. Fractions from the second peak of 
a Sephadex G-50 column equilibrated with 0.05 M pH 4.3 acetate buffer were pooled and the 
pH adjusted to 8 with 1 M  Tris-HCl. The MBP was concentrated  (602 /zg/ml) and stored 
at -70°C. Samples, 12/zg,  were analyzed, either reduced with DTI" (right), or not reduced 
(left)  (11). The india ink mark at the bottom of the gels indicates the position of the pyronin 
Y marker at the conclusion of electrophoresis. 320  PROPERTIES  OF  MAJOR  BASIC  PROTEIN 
FIG. 3.  Analysis of MBP  on  SDS  polyacrylamide gels.  MBP  Containing fractions in pH 
4.3 acetate buffer were  adjusted to pH 8  with  1 M  Tris-HC1 and  DTT,  final concentration 
0.01 M, was added. The MBP was concentrated using an Amicon UM-2  membrane (Amicon 
Corp.,  Lexington, Mass.)  and  the concentrate was left  at  20°C  for 3  days. Before  analysis 
additional DTT was added  to  the sample on the left. Note  that both gels have "caps", but 
the gel on the right reveals a  series of prominent bands above the MBP band. GLEICH~  LOEGERING~  KITEPPERS~ BAJA3~ AND MANN  321 
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Fla. 4.  Determination of the number of amino acid residues in MBP.  Reduced and car- 
boxymethylated  MBP was  analyzed  by gel filtration on a  calibrated  10cyo agarose column 
equilibrated with 6 M guanidinium chloride. Briefly, MBP in 0.2 M acetic acid was lyophilized, 
the resulting powder taken up in pH 8.6 6 M  guanidinium chloride, reduced in 0.1  M  mer- 
captoethanol for 18 h at 20°C, and carboxymethylated with an excess of iodoacetie acid (22). 
In 4 a, Vo (void volume) is the elution position of the  blue dextran and Vo +  Vi is the elu- 
tion position  of DNP-alanine  (Vi is  the column internal  volume). The elution position  of 
MBP is intermediate between these markers.  In 4 b, the calibration  data  for  10%  agarose 
column are shown. N  refers to the number of residues in the polypeptide and erfc  -I Kd is the 
inverse error function complement of Kd.  Kd is the distribution coefficient for the column. 
Closed circles represent  the standards  of known sequence and  thus  the number of residues 
(23). The arrow indicates the erfc  -1 Kd for MBP. 
effect  of  the  MBP  on  vascular  permeability  in  the  skin  and  the  results  are 
shown in Table IV. Injection of various amounts  of MBP  up to.  11/~g did  not 
increase  vascular  permeability.  Injection of the first  peak  from  the  Sephadex 
G-50  gel  filtration  columns  increased  vascular  permeability  slightly  and  the 322  PROPERTIES OF  MAJOR BASIC PROTEIN 
TABLE I 
Amino Acid Composition of MBP 
Amino  acid  No. of residues 
Aspartic  6 
Threonine  4 
Serine  4 
Glutamic  8 
Proline  5 
Glycine  12 
Alanine  8 
Valine  9 
Methionine  1 
Isoleucine  2 
Leucine  4 
Tyrosine  4 
Phenylalanine  5 
Histidine  3 
Lysine  2 
Arginine  13 
Tryptophan*  4 
Cysteine~  6 
Total  100 
* After hydrolysis in 3N p-toluene sulfonic acid (19, 20). 
:~ As cysteic acid. 
TABLE II 
Molecular Weight of MBP 
SDS polyacrylamide  11,102 
Amino acid composition  11,350 
Gel filtration  10,800 
The value for SDS polyacrylamide represents the mean of 16 individual determinations 
and for gel filtration, two determinations. The accuracy of the molecular weight determined 
by SDS polyacrylamide is ±10% and by gel filtration, +5%. In the case of the SDS poly- 
acrylamide determinations the values used for calculation of molecular weight of MBP were 
those of dimers, trimers, and tetramers, the mobilities of which were bracketed by the stand- 
ards  (9,  11). The amino acid composition value represents  the  minimal molecular weight 
based on one residue of methionine. 
controls using histamine, bradykinin, and the  histamine releasor 48/80  were 
clearly positive. To  determine whether  MBP  might neutralize histamine or 
bradykinin we mixed these materials with MBP and then injected them into 
guinea pig skin. No inhibition of the activity of the histamine on the perme- 
ability of  cutaneous vessels  was  found nor  was  there  any inhibition of  the 
reactivity of bradykinin or 48/80. 
We also examined the activity of the MBP on the guinea pig ileum using a GLEICIi~  LOEGERING~  KUEPPERS,  BAJAJ,  AND  MANN  323 
TABLE III 
Available Sulfhydryl Groups in MBP* 
Material  Free SH tool/tool 
MBP 
Exp. 1  2.14 
Exp. 2  2.13 
Dithiothreitol  2.05 
* MBP, 2.08 X  10  -2 #M in a vol of 0.6 ml of 0.05 M pH 4.3 acetate buffer, was added to 
2.4 ml of 2% SDS, 0.08 M pH 8 sodium phosphate containing EDTA 0.5 mg/ml, and incu- 
bated at 50°C for 20 rain. The resultant  pH was 7.8. DTNB, 0.1 ml of 4 mg/ml in 0.1 M 
pH 8 phosphate,  was added and the color developed for 15 rain at room temperature  before 
reading at 410 nm (15). 
Schultz-Dale gut bath and the results of certain of these experiments are shown 
in Table V. Addition of MBP  to the  bath  solution  did  not  contract  the  gut 
either immediately or in a delayed fashion and this was so regardless of whether 
or not  atropine  was  added  to reduce muscle irritability.  The amounts  added 
were comparable,  on a  molar  basis,  to  the quantities  of histamine  which  are 
regularly  active on the  gut. Three  experiments  were performed  to determine 
whether MBP could block the action of histamine on the gut. In one of these 
(Table  V,  tests 2  and 3)  there were modest reductions,  26 %  and 35 %,  in the 
amplitude  of contraction  when  the  gut was preincubated  with  MBP.  In the 
second experiment (Table V, test 4) there was a slight increase in the amplitude 
of contraction. In the third experiment (not shown), reductions, 26 % and 38 %, 
in the amplitude of contraction were noted in two of five tests,  but reductions 
of  the  same  magnitude,  33%  and  35%,  were  noted  after  incubation  with 
neutralized column buffer only. In none of these experiments did we observe a 
stepwise  increase  in  the  response  of the  gut  to  histamine  (5).  Preincubation 
with fraction I  from the Sephadex G-50 column did not alter the contraction of 
the gut by histamine. Mixing MBP with histamine or with bradykinin did not 
alter the reactivity of the gut to these materials. 
Because of prior reports that histones and neutrophil basic proteins are bac- 
tericidal,  we investigated  the bactericidal  properties  of the MBP  with several 
organisms  including  Staphylococcus  epidermidis,  Proteus  vulgaris,  S.  aureus, 
Streptococcus pyogenes, and two strains of Escherichia  coli. Whereas histone was 
very active in suppressing the growth of S. epidermidis,  P. vulgaris, and E. coli, 
MBP  did not reduce the growth of any of the organisms save for E. coll 182 
(25/~g for 50 %  inhibition). 
The  MBP  was  tested  for  esterotytic  activity  using  the  synthetic  esters 
TAME  and ATEE. No hydrolysis of either  substrate  was detected.  Also the 
MBP had no trypsin inhibitory activity using both TAME and ATEE as sub- 
strates  of trypsin.  In these assays the molar ratio of MBP  to trypsin  was 34 324  PROPERTIES  OF  MAJOR  BASIC  PROTEIN 
TABLE IV 
Effect of the MBP on Cutaneous  Vascular  Permeability* 
Test material  Exp. 1  Exp. 2  Exp. 3  Exp. 4 
MBP 
11 #g  Neg~  3 Tr 
1 #g  Neg  3 Tr 
5.4 #g  5 Tr  5 MP 
Peak I§  6 P  6 MP 
Histamine 
1/zg  9 MP  10 M  12 M  13 M 
0.5#g  9 P  6P 
Bradykinin 
1 #g  9 M  10 MS 
0.5 #g  8 MP  10 MS  9 S  8 S 
48/80 
1/zg  8 MP  7 M  6 M  7 MS 
2/zg  9 M  5 MP 
NaC1  2 Tr  2 Tr  2 Tr  5 MP 
3 Tr  2 Tr 
Histamine,  1.0/~gll +  MBP, 5.4 #g  11 M  13 M 
Bradykinin, 0.5/~g[[ +  MBP, 5.4 #g  10S  9S 
48/80, 1 ~gfl +  MBP, 5.4/zg  9 MP  6 MP 
* Guinea pigs weighing from 470 to 680 g were injected intravenously  with 0.5 ml of 1% 
Evans blue dye and immediately thereafter  the  test  materials were injected  intracutane- 
ously. The animals were sacrificed after  15 min and the  reactions graded  by the average 
diameter of the blue spot and by the intensity of color: trace (Tr), pale (P), moderate-pale 
(MP), moderate (M), moderate-strong (MS), and strong (S) (27). 
:~ Less than 0.15 M NaC1 control. 
§ Absorbance at 280 nm was 0.73 which corresponds roughly to 28 #g/0.1 ml injection site, 
using the same extinction coefficient  as used for MBP. 
II Histamine, bradykinin, and 48/80 were mixed with freshly prepared MBP in glass tubes 
at room temperature  about 15-20 min before injection. 
(10 #g trypsin) and 85  (4 #g trypsin), respectively. Because of the presence of 
free sulfhydryl groups in the MBP we determined whether it might alter the 
activity of papain, a sulfhydryl dependent protease (32). In the first experiment, 
papain was activated with cysteine and separated from excess cysteine by gel 
filtration on  Sephadex  G-25.  The activated  papain was  then incubated with 
MBP and BAEE. Rather than inhibiting the activity of papain, we found that 
MBP increased its activity by 72 %. This result suggested that the enzyme was GLEICH,  LOEGERING~ KUEPPERS,  BAJAJ~ AND  MANN 
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Test  Material tested  Contrac-  tion, units 
1  MBP, alkylated,  10 #g  0 
MBP, 23 #g  0 
18.7/zg  0 
5.6 #g  0 
Fraction I from G-50 column, 14/zg  0 
MBP, 5.6 #g, incubated with gut for 23 min followed by histamine, 100 ng  52 
Histamine, 100 ng  70 
MBP, 18.7/zg, incubated with gut for 17 min followed by histamine, 50 ng  17 
Histamine, 50 ng  26 
MBP, 18.7 #g, incubated with gut for 30 rain followed by histamine, 100 ng  40 
Histamine, 100 ng  36 
5  Fraction I, 14 #g, followed after 17 min by histamine, 50 #g  49 
Histamine, 50/zg  54 
6  Histamine, 25 ng  54 
Histamine, 25 ng+ MBP, 7.7 #g  52 
7  Bradykinin,  12.5 ng  48 
Bradykinin, 12.5 ng +  MBP, 7.7/zg  47 
MBP, histamine, bradykinin, or mixtures of these were added to the 5-ml gut bath chamber 
and the response noted. In experiments 2-4, testing the ability of MBP to alter the reactivity 
of gut to histamine, the protein was freshly prepared by gel filtration of granules solubilized 
in 0.01 M HC1 and fractions from the second peak were neutralized by addition of 1 M Tris- 
HC1, pH 8. The protein was added to the gut bath and incubated, and histamine was added. 
The response of the gut to histamine alone was measured several times immediately  before 
addition of MBP and also after the mixture of MBP and histamine had been washed from 
the chamber. In experiments 6 and 7, MBP was added to histamine or bradykinin and  the 
mixture was added directly to the gut bath. Units are the number of millimeters of deflection 
on the recorder. 
maintained in its active form by the MBP. We next determined whether the 
MBP  could  activate  mercuripapain and  the  results  of  this  experiment  are 
shown in Fig. 5. Addition of MBP to mercuripapain resulted in a  definite in- 
crease in the activity of the enzyme. Comparison of the ability of cysteine and 
MBP  to  activate  mercuripapain showed  that  MBP  was  approximately  1.3 
times as active as cysteine on a molar basis. These experiments indicate that the 
sulfhydryl groups in the MBP are readily available and are capable of activating 
an enzyme which requires a free sulfhydryl group for its proteolytic action. 
Because of the basic character of the MBP we tested its ability to interact 326  PROPERTIES  OF  MAJOR  BASIC  PROTEIN 
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FIG. 5.  Activation of papain  by cysteine and MBP. Mercuripapain,  54 #g in pH 6.2 0.02 
acetate-0.025  M phosphate  buffer, was incubated with either cysteine or MBP for 5 min at 
20°C, final vol 1 ml. The substrate  was 0.041 M  BAEE, containing  0.0004 M  EDTA. A 
sample of MBP or cysteine and enzyme, 0.1 ml, was added to 1.0 ml of BAEE and 1.0 ml of 
3 M NaC1. The rate of hydrolysis of BAEE was determined by addition  of 0.01 M NaOH. 
Open circles denote the effect of cysteine. 
with acidic molecules such as DNA. It is known that histones will precipitate 
with DNA (31),  and we determined  whether  the MBP would also precipitate 
with  DNA.  Mixing  of MBP  and  DNA  resulted  in  immediate  turbidity  and 
within minutes a stringy precipitate formed. 
Finally,  the  ability  of the  MBP  to neutralize  the  effect  of heparin  on  the 
clotting time of freshly drawn  guinea pig blood was determined.  Both prota- 
mine and MBP neutralized heparin and addition of either of these proteins  to 
heparin  resulted  in  the  formation  of opalescence.  While  protamine  by  itself 
did  not  alter  the  clotting time  appreciably,  MBP  increased  the  clotting  time 
from three to fivefold in two experiments. 
DISCUSSION 
In  these  experiments  we  have  characterized  a  protein  isolated  from  the 
granules of guinea pig eosinophils.  This material  accounts for the bulk of the 
protein in solubilized eosinophil granules, is of relatively low molecular weight, 
and has an isoelectric point of 10 or greater (9). In our prior experiments eosino- 
phil  granules  prepared  from  purified  eosinophils  were  solubilized  in 0.01  M 
HCI  and  fractionated  by gel  filtration  on  Sephadex  G-50  columns.  Because 
purification of eosinophils from the peritoneal  cell mixtures limits the yield of 
granules and thus of MBP,  we determined  whether granules could be directly GLEICH,  LOEGERING,  KUEPPERS,  BAJAJ,  AND  MANN  327 
purified from the peritoneal cell mixtures. We found that the resulting granule 
preparations were as homogeneous as those from purified eosinophils and the 
yield of MBP was increased about fourfold. Analysis of the MBP-containing 
fractions from the Sephadex G-50 column by electrophoresis in urea-acetic acid 
polyacrylamide gels  often revealed  a  single  band  but  after concentration or 
freezing and thawing,  a series of bands were found (Fig.  1). Even though we 
varied  the  conditions  during  disruption of granules,  the finding  of multiple 
bands after concentration or storage of MBP was repeatedly observed. When 
the  MBP  was  analyzed  by  SDS  polyacrylamide electrophoresis,  we  found 
that protein which was concentrated and frozen did not enter the gel unless it 
was  reduced with DTT  (Fig.  2).  In  contrast freshly prepared  MBP  usually 
yielded single major bands. Thus the apparent inhomogeneity of the MBP is 
due to a marked propensity of the protein to aggregate and this is particularly 
evident when the protein is concentrated or when it was stored before analysis, 
We found that the additional bands represented polymers of a monomer with a 
mol  wt of  11,100.  Reduction of the polymerized MBP  before electrophoresis 
largely abolished the polymers and increased the intensity of staining of the 
major band  (Fig. 3).  Furthermore, we found that storage of the MBP in the 
presence of disulfide-reducing agents  such  as  mercaptoethanol  or  DTT  pre- 
vented or markedly reduced the formation of polymers. Alkylation of freshly 
prepared MBP with iodoacetamide prevented the formation of polymers. These 
results indicate that  the  MBP  is  a  single  component and  that  the apparent 
inhomogeneity is due to the formation of a series of polymers produced by the 
formation of  disulfide  bonds.  Further  evidence  for  the  conclusion  that  the 
MBP is a unique homogeneous protein is the preliminary finding from amino 
acid sequence studies which show that single amino acids are found at residues 
1-103 
The tool wt of the MBP as determined by gel filtration on columns of 10% 
agarose equilibrated with 6 M guanidinium chloride was 10,800, a value in good 
agreement (a) with that derived from the studies on SDS polyacrylamide gels 
and (b) with the minimal molecular weight (based on one residue of methionine) 
from amino  acid  composition  (Table II).  Amino  acid  analyses of the  MBP 
revealed that it contained 13 % arginine, accounting for its high isoelectric point. 
In  addition,  four residues of tryptophan are present,  a  finding which  estab- 
lished  the  protein  as  distinct from histones  which  are  devoid of tryptophan 
(31). Finally, the MBP contains less  than  1% carbohydrate. 
We have conducted a variety of experiments to determine whether the MBP 
possesses biological  properties  comparable to  the  basic  proteins from rabbit 
neutrophil granules (33-37). In contrast to basic proteins derived from neutro- 
phil granules, our experiments indicate that  the eosinophil MBP does not in- 
crease vascular permeability. In addition it does not contract the guinea pig 
2  Fass, D. N., K. G. Mann, and G. J. Gleich. Unpublished observations. 328  PROPERTIES  OF  MAJOR  BASIC  PROTEIN 
ileum. The MBP does not inhibit histamine or bradykinin and did not interfere 
with the activity of the histamine releasing compound, 48/80.  Incubation of 
guinea pig ileum with MBP did not consistently reduce the amplitude of con- 
traction after addition of histamine. These results differ from those reported by 
Vercauteren and Peeters, but they used considerably larger amounts, up to 2.4 
mg of crude extract of horse eosinophil granules  (5). Also their extracts con- 
tracted the gut while the guinea pig MBP did not. Our results with bradykinin 
also differ from those of Archer and Broome who showed that aqueous extracts 
and their ultrafiltrates inhibited the production of edema in horse skin by brady- 
kinin (38). However, the biological reaction in the horse may not be analogous 
to the tests of MBP on vascular permeability and gut contractibility we have 
performed. Finally  in  contrast  to neutrophil  basic  proteins  and histone  (25, 
35, 36, 39) which show striking antibacterial activity, the MBP displays little 
such activity, and in the one instance in which activity was detected it was con- 
siderably less than that found with histone. 
The physiochemical structure of the MBP, namely, its marked basicity and 
the presence of two available  sulfhydryl groups, suggested  that  the  protein 
might interact with acidic molecules and with enzymes which depend on  the 
presence of sulfhydryl groups for their activity. Mixing the MBP  with  DNA 
resulted in a marked increase in turbidity and the formation of a stringy pre- 
cipitate. Also the MBP was found to activate papain and in  this  respect  was 
more active on a molar basis than cysteine. We did not detect any enzymatic 
activity in the MBP when it was incubated with ATEE and TAME nor did it 
inhibit trypsin. The MBP neutralized the anticoagulant activity of heparin and 
its activity in this respect was comparable to that of protarnine. When added to 
guinea pig blood, it prolonged the clotting time.  Saba  and his  associates  (40) 
have  shown  that  the  cationic protein  fraction of rabbit  polymorphonuclear 
leukocytes exerts a potent anticoagulant effect on human blood in vitro. Their 
results  suggested  that  the  cationic proteins  interfered with  the  formation of 
intrinsic  thromboplastin.  Earlier, Archer  had  shown  that  extracts  of  whole 
eosinophils possess heparin-neutralizing activity, but these extracts were pre- 
pared from whole cells and therefore may have contained histones (41). 
Our findings do not point to any unique biological activity associated with 
the MBP other than those which one would expect of a protein as basic as this 
and  which  possesses  reactive sulfhydryl groups.  However, the  ability of the 
eosinophil to deposit  this material  in tissue when free granules  are liberated 
could  modify  a  variety  of  biological  reactions.  Bosworth  and  Archer  have 
found that exposure of bacteria to lysed rat eosinophils promoted phagocytoses 
by monocytes and neutrophils (42). In preliminary experiments we have found 
that the MBP readily precipitates with proteins such as bovine serum albumin 
and rabbit IgG,  and it binds to erythrocytes. Thus the MBP may alter bio- 
logical reactions by adhering to acidic groups on cell membranes and altering 
the reactivity of receptors or other properties of membranes (43). Further, Chen GLEICH,  LOEGERING,  KUEPPERS,  BAJAJ,  AND  MANN  329 
and Hirsch have shown that mercaptoethanol can substitute for macrophages 
in  the  Mishell-Dutton  culture  system  (44,  45)  and  Broome  and  Jeng  have 
reported that mouse lymphoid tumors showed growth promotion when thiols, 
such as cysteine and mercaptoethanol, were added to standard culture media 
(46). Eosinophils appear in lymph nodes after administration of antigen (47), 
presumably in response to chemotactic factors derived from lymphocytes (48, 
49), and are prominent in human lymphoma tissue (2). Perhaps a function of 
eosinophils  is  the  regulation  of  the  growth  of lymphoid  cells  through  the 
activity of the thiol-rich MBP. 
SUMMARY 
Guinea pig eosinophil granules are characterized by the presence of a basic 
protein of low molecular weight which accounts for greater than 50% of granule 
protein. This protein, termed the major basic protein (MBP), readily aggregates 
and becomes insoluble,  and the formation of aggregates is dependent on the 
establishment of disulfide bonds. Analysis of concentrated preparations of MBP 
often revealed  a  series  of bands  which  were multiples  of a  monomeric unit 
with  a  tool  wt  of approximately  II,000.  Analysis  of reduced  and  alkylated 
MBP on a  10%  agarose column equilibrated with 6 M  guanidinium chloride 
revealed a single polypeptide chain with a mol wt of 10,800. Amino acid analysis 
of the protein revealed the presence of 13 % arginine, consistent with the basic 
character of the molecule. Four residues of tryptophan, were present, indicating 
that MBP is not a  histone. The MBP did not increase vascular permeability 
when injected into the skin of guinea pigs, nor did it antagonize the effect of 
histamine and bradykinin in the skin. MBP also did not contract the isolated 
guinea pig ileum and when mixed with histamine or bradykinin did not inhibit 
their activity on the gut. MBP had only weak, if any, antihistaminic activity. 
MBP possessed weak bactericidal activity when compared to histone and then 
only with one strain of E.  coli.  MBP precipitated DNA,  neutralized heparin, 
and activated papain. On a molar basis MBP was more active than cysteine in 
activating papain. These results do not point to any unique biological activity 
associated with MBP other than those expected of a  protein as basic as it is 
and  one  which  possesses  reactive  sulfhydryl  groups.  Possible  functions  of 
eosinophils based on the properties of the MBP are discussed. 
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